CALGARY, AB – Decibel Cannabis Company Inc., a market leader in premium cannabis and extract manufactured products, is pleased to announce that it has received final acceptance from the TSX Venture Exchange (the “TSXV”) granted acceptance for Decibel Cannabis Company Inc.’s acquisition of AgMedica Bioscience Inc. pursuant to an assignment agreement entered into with Callisto Capital Corp. in exchange for a $6.3 million unsecured convertible debenture. As a result of receiving the acceptance, Decibel completed the conversion and issued 114,545,455 common shares to Callisto.
The conversion of the Debenture was conditional upon receipt of final TSXV acceptance for the acquisition of AgMedica pursuant to Exchange Policy 5.3, which would have required disinterested shareholder approval of Callisto as a “Control Person” (as such term is defined in the rules and policies of the TSXV), if…
